Angela Watson

Doctor of Osteopathic Medicine,  Toronto General - University Health Network 

Location: India

Consulting Services

Sales and Marketing Grant Submission Hospital-Pharmacy-Insurance Admin and Customer Support Legal Support

Areas Of Interest

Phenytoin Arthropod Antennae Heteropneustes Laryngostenoses Replication Units ACTH Endorphin Precursor Graft Pancreatitis Drift, Genetic Ocular Infections, Viral Growth Suppressor Gene Transferrin-Binding Protein B Bacteriophage Pf1 Aneurysms, Fusiform Research Methodology Gastric delta Cells Granulosa Lutein Cells Calcium Dobesilate Monoammonium Salt edodes, Lentinula Phenazocine Hydrobromide Receptor, Interleukin-13 Dilleniaceae Contraception Failure Hemiparaplegic Syndrome Trial Protocols Breadboard Project Detergents, Synthetic Bone Morphogenetic Protein 3B Apophyses, Bony MC-1288

Professional Narrative

Dr. Angela Watson was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Watson has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Senior Director, Harvard Med 1999
Assistant Professor, Mayo Clinic 2003

Education

Bachelor of science in nursing, Perelman School of Medicine 2001
Doctor of medicine, Harvard Medical School 2019

Referees


Publications

Platt RJ, Chen S, Zhou Y, Yim MJ, Swiech L, Kempton HR, Dahlman JE, Parnas O, Eisenhaure TM, Jovanovic M, Graham DB, Jhunjhunwala S, Heidenreich M, Xavier RJ, Langer R, Anderson DG, Hacohen N, Regev A, Feng G, Sharp PA, Zhang F. CRISPR- Cas9 knockin mice for genome editing and cancer modeling. Cell. 2014 Oct 9;159(2):440-55. doi: 10.1016/j.cell.2014.09.014. Epub 2014 Sep 25. PMID: 25263330; PMCID: PMC4265475.

Reichmuth AM, Oberli MA, Jaklenec A, Langer R, Blankschtein D. mRNA vaccine delivery using lipid nanoparticles. Ther Deliv. 2016;7(5):319-34. doi: 10.4155/tde-2016-0006. Erratum in: Ther Deliv. 2016 Jun;7(6):411. PMID: 27075952; PMCID: PMC5439223.

Gupta A, Andresen JL, Manan RS, Langer R. Nucleic acid delivery for therapeutic applications. Adv Drug Deliv Rev. 2021 Nov;178:113834. doi: 10.1016/j.addr.2021.113834. Epub 2021 Sep 4. PMID: 34492233.

Hou X, Zaks T, Langer R, Dong Y. Lipid nanoparticles for mRNA delivery. Nat Rev Mater. 2021;6(12):1078-1094. doi: 10.1038/s41578-021-00358-0. Epub 2021 Aug 10. PMID: 34394960; PMCID: PMC8353930.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :